Increasing inclination towards cosmetic procedures for several aesthetic treatments, growing adoption rate by geriatric individuals, and rising preference of minimally invasive & noninvasive aesthetic procedures are anticipated to boost the growth of botox market over the forecast period. Moreover, extensive research & development and awareness programs conducted by major companies across the globe for introducing new botox products is expected to contribute in increasing use of botox injections for several non-surgical cosmetic procedures. For instance, in June 2019; Evolus, Inc. launched #NEWTOX NOW consumer conversion program for rapid adoption of Jeuveau. It is a purified botulinum toxin type A formulation used for the temporary improvement in appearance of moderate to severe glabellar lines in adults.
Major Key Players of the Botox Market are:
Allergan, Ipsen Group, Medytox, Merz Pharma, HUGEL, US WorldMeds, Galderma Laboratories, L.P., Revance Therapeutics, Inc, Eisai Co., Ltd. and DAEWOONG CO.LTD among others.
According to American Society of Plastic Surgeons (ASPS), in 2018, there were more than 17.7 million surgical and minimally-invasive cosmetic procedures performed in the United States. In 2018, 15.9 million cosmetic minimally-invasive procedures were performed, out of which 7.44 million procedures used botulinum toxin type A during procedure. There has been rise of 4% for the use of botulinum toxin type A since 2017. Hence, the increasing preference of cosmetic minimally-invasive procedures with the application of botulinum toxin, in several developed and developing regions aid in substantial growth of the botox market.
Increasing number of new product launches by key players is contributing in the growth of Botox Market. For instance, in 2019 Huons Global launched Liztox, a new botulinum toxin (BTX) product for treating forehead wrinkles in Korea. Moreover, several new botulinum toxin type A products are receiving approvals in specific regions. For instance, in 2019, Evolus, Inc. received European Commission (EC) approval for marketing of Nuceiva. It is a purified botulinum toxin type A formulation for temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown in adults below 65 years of age. Hence the increasing availability of wide range of botulinum products across wide regional horizon is attributed to the market growth.
The Botox Market is segmented on the basis of Types, Applications and region.
Major Types of Botox Market covered are:
- Botulinum Toxin Type A
- Botulinum Toxin Type B
Major Applications of Botox Market covered are:
- Aesthetics
- Therapeutics
No comments:
Post a Comment